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1. General Information 
Solvents were purified by passage through solvent purification columns and 
further degassed with argon. 1  Commercially available liquid reagents were 
degassed by three freeze pump thaw cycles (for volatile substrates) or under 
vacuum (for nonvolatile substrates) prior to entering the glove box. Terminal olefins, 
sodium periodate and CeCl3 heptahydrate were purchased from Aldrich and used 
as is. 
 Standard NMR spectroscopy experiments were conducted on a Varian 
INOVA 500 (1H: 500 MHz, 13C: 126 MHz) or a Bruker Avance HD 400 (1H: 400 
MHz, 13C: 101 MHz, equipped with a cryoprobe) spectrometer. Chemical shifts are 
referenced to the residual solvent peak (TMS). Multiplicity is reported as follows: 
(s: singlet, d: doublet, t: triplet: q: quartet, br: broad, m: multiplet). Spectra were 
analyzed and processed using MestReNova. High-resolution mass spectra were 
provided by the California Institute of Technology Mass Spectrometry Facility using 
JEOL JMS-600H High Resolution Mass Spectrometer. 
  
                                                        
1 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J., Organometallics 1996, 
15, 1518-1520. 
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2. Experimental 
 
i) Synthesis of substrates 
 
 
ethyl (E)-2-methylhepta-2,6-dienoate (5a): Synthesized according to the general 
procedure from Murphy et al.2 An oven-dried round bottom flask was flushed with 
argon and triethyl 2-phosphono propionate (2.30 mL, 11.0 mmol, 1.1 equiv)  was 
added to a stirring solution of NaH (60% dispersion in mineral oil, 0.440 g, 11 mmol, 
1.1 equiv) in anhydrous THF (30 mL) at 0 °C. After 30 minutes, 4-pentenal (0.987 
mL, 10.0 mmol, 1.0 equiv) was then added dropwise and the reaction was stirred 
for 30 minutes at 0 °C. The reaction was allowed to warm to ambient temperature 
and stirred for an additional 3 hr. The reaction mixture was quenched with water 
(20 mL) and diluted with EtOAc (60 mL). The separated organic phase was then 
washed with brine (20 mL), dried with Na2SO4 and concentrated in vacuo to yield 
a crude 5.9:1 mixture (E:Z). Rf (5% Et2O in hexanes): 0.55 (Z isomer), 0.45 (E 
isomer). The title compound was purified by silica gel column chromatography (1% 
to 1.5% Et2O in hexanes) to yield a clear colorless oil (1.056 g, 63% yield). 1H NMR 
(400 MHz, CDCl3, ppm) δ 6.74 (tq, J = 7.3, 1.5 Hz, 1H), 5.81 (ddt, J = 16.6, 10.2, 
6.4 Hz, 1H), 5.05 (dq, J = 17.1, 1.6 Hz, 1H), 5.00 (ddt, J = 10.2, 1.9, 1.2 Hz, 1H), 
4.18 (q, J = 7.1 Hz, 2H), 2.30- 2.17 (m, 4H), 1.84 (dd, J = 1.6, 0.8 Hz, 3H), 1.29 (t, 
J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3, ppm) δ 168.6, 141.7, 128.6, 115.7, 
                                                        
2 Murphy, S. K.; Coulter, M. M.; Dong, V. M. Chem. Sci. 2012, 3, 355–358. 
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60.9, 33.0, 28.5, 14.7, 12.8. HRMS (EI+): m/z calculated for [C10H16O2]+: 168.1150, 
found: 168.1146.  
Note: The Z isomer was also isolated (66 mg, 4%). For a more selective synthesis 
of the Z isomer, see the following Still-modified HWE procedure. 
 
 
ethyl (Z)-2-methylhepta-2,6-dienoate (5b): Synthesized according to the Still-
modified HWE procedure reported by Snider and Kiselgof.3 An oven-dried round 
bottom flask was flushed with argon and charged with 18-crown-6 (13.2 g, 50.0 
mmol, 5.0 equiv). THF (200 mL) and triethyl 2-phosphono propionate (2.14 mL, 
10.0 mmol, 1.0 equiv) were added, and the flask was cooled to -78 °C. KHMDS 
(20 mL, 0.5 M in Toluene, 10.0 mmol, 1.0 equiv) was then added dropwise, with 
the solution turning pale orange towards the end of the addition. 4-pentenal (0.987 
mL, 10.0 mmol, 1.0 equiv) was then added, and the mixture was stirred at -78 °C 
for 90 minutes. The reaction was warmed to -30 °C, and then quenched with 
saturated NH4Cl (30 mL). The mixture was extracted with Et2O (2 x 75 mL) and 
the combined organic phases were washed with brine (50 mL), dried with MgSO4 
and concentrated in vacuo. The crude product was determined to be a 1:2.5 
mixture (E:Z). The title Z isomer was isolated by column chromatography (1% to 
2.5% Et2O in hexanes) to yield a clear colorless oil (397 mg, 24%). 1H NMR (400 
                                                        
3 Snider, B. B.; Kiselgof, J. Y. Tetrahedron 1998, 54, 10641–10648. 
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MHz, CDCl3, ppm) δ 5.92 (tq, J = 7.3, 1.5 Hz, 1H), 5.81 (ddt, J = 16.9, 10.2, 6.6 Hz, 
1H), 5.03 (dq, J = 17.1, 1.7 Hz, 1H), 4.97 (ddt, J = 10.2, 2.0, 1.3 Hz, 1H), 4.19 (q, 
J = 7.1 Hz, 2H), 2.55 (qq, J = 7.4, 1.4 Hz, 2H), 2.16 (dtt, J = 7.3, 6.6, 1.3 Hz, 2H), 
1.89 (q, J = 1.4 Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3, ppm) 
δ 168.5, 142.4, 138.4, 128.0, 115.4, 60.5, 33.8, 29.2, 21.0, 14.7. HRMS (EI+): m/z 
calculated for [C10H16O2]+: 168.1150, found: 168.1146. 
 
 
ethyl (E)-2-ethylhepta-2,6-dienoate (5c): An oven-dried round bottom flask was 
flushed with argon and triethyl 2-phosphonobutyrate (2.61 mL, 11.0 mmol, 1.1 
equiv)  was added to a stirring solution of NaH (60% dispersion in mineral oil, 0.440 
g, 11 mmol, 1.1 equiv) in anhydrous THF (30 mL) at 0 °C. After 30 minutes, 4-
pentenal (0.987 mL, 10.0 mmol, 1.0 equiv) was then added dropwise and the 
reaction was stirred for 30 minutes at 0 °C. The reaction was allowed to warm to 
ambient temperature and stirred for an additional 3 hr. The reaction mixture was 
quenched with water (20 mL) and diluted with EtOAc (60 mL). The separated 
organic phase was then washed with brine (20 mL), dried with Na2SO4 and 
concentrated in vacuo to yield a crude 5.9:1 mixture (E:Z). Rf (5% Et2O in 
hexanes): 0.55 (Z isomer), 0.45 (E isomer). The title compound was purified by 
silica gel column chromatography (1% to 1.5% Et2O in hexanes) to yield a clear 
colorless oil (398 mg, 22% yield). 1H NMR (400 MHz, CDCl3, ppm) δ 6.70 (t, J = 
7.3 Hz, 1H), 5.82 (ddt, J = 16.7, 10.2, 6.4 Hz, 1H), 5.05 (dq, J = 17.1, 1.6 Hz, 1H), 
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5.00 (d, J = 10.2 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 2.35 – 2.24 (m, 4H), 2.23 – 2.15 
(m, 2H), 1.29 (t, J = 7.2 Hz, 3H), 1.00 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, 
CDCl3, ppm) δ 168.0, 141.0, 137.7, 134.6, 115.4, 60.5, 33.0, 27.9, 20.2, 14.4, 14.0; 
HRMS (EI+): m/z calculated for [C11H19O2]+: 183.1385, found: 183.1401. 
The Z-isomer was also isolated from this reaction: 
 
ethyl (Z)-2-ethylhepta-2,6-dienoate (5d): The Z-isomer was isolated from the 
early fractions of the column to yield a clear oil (147 mg, 8% yield). 1H NMR (400 
MHz, CDCl3, ppm) δ 5.87 – 5.76 (m, 2H), 5.03 (dq, J = 17.1, 1.7 Hz, 1H), 4.98 (ddt, 
J = 10.2, 2.0, 1.2 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 2.51 (q, J = 7.6 Hz, 2H), 2.27 
(qq, J = 7.4, 1.2 Hz, 2H), 2.17 (q, J = 7.4 Hz, 1H), 1.30 (t, J = 7.1 Hz, 3H), 1.02 (t, 
J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 168.2, 139.3, 138.0, 134.2, 115.0, 
60.1, 33.5, 28.7, 27.5, 14.3, 13.7. HRMS (EI+): m/z calculated for [C11H19O2]+: 
183.1385, found: 183.1410.  
 
 
diethyl 2-(pent-4-en-1-ylidene)malonate (5e):  
To a solution of 4-pentenal (0.987 mL, 10 mmol, 1 equiv) in CH2Cl2 (5 mL) was 
added diethyl malonate (1.68 mL, 11 mmol, 1.1 equiv), glacial acetic acid (57 µL, 
1 mmol, 0.1 equiv) and piperidine (99 µL, 1 mmol, 0.1 equiv). The mixture was 
stirred at room temperature for 6.5 hr, at which point it was diluted with 100 mL 
EtOAc, washed with NaHCO3 (30 mL) and brine (30 mL), dried with Na2SO4 and 
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concentrated in vacuo. The title compound was purified by column 
chromatography (5-10% EtOAc in hexanes) to yield a clear and colorless oil (314.3 
mg, 14%). 1H NMR (400 MHz, CDCl3, ppm) δ 6.99 (t, J = 7.7 Hz, 1H), 5.80 (ddt, J 
= 16.8, 10.2, 6.5 Hz, 1H), 5.10-5.00 (m, 2H), 4.30 (q, J = 7.1 Hz, 2H), 4.24 (q, J = 
7.1 Hz, 2H), 2.41 (q, J = 7.5, 7.1 Hz, 2H), 2.28-2.21 (m, 2H), 1.33 (t, J = 7.1 Hz, 
3H), 1.29 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 165.5, 163.9, 148.5, 
136.7, 129.0, 115.9, 61.3, 61.2, 32.2, 29.0, 14.2, 14.1; HRMS (EI+): m/z calculated 
for [C12H9O4]+: 227.1283, found: 227.1291. Note: the main byproduct was assigned 
as the aldehyde homoaldol/dehydration product (577 mg, 77%). 
 
 
ethyl (E)-4,4-dimethylhepta-2,6-dienoate (5f): An oven-dried round bottom flask 
was flushed with argon and charged with NaH (0.359 g, 9.0 mmol, 1.5 equiv) and 
THF (20 mL). The stirring mixture was cooled to 0 °C, and 
triethylphosphonoacetate (1.789 mL, 9.0 mmol, 1.5 equiv) was added. After 20 
minutes, 2,2-Dimethyl-4-pentenal (0.815 mL, 6.0 mmol, 1.0 equiv) was then added 
dropwise and the reaction was stirred for 30 minutes at 0 °C. The reaction mixture 
was allowed to warm to ambient temperature and refluxed at 80°C for 2 hours. The 
reaction mixture was quenched sequentially with a saturated Na2CO3 solution (5 
mL), water (5 mL), and brine (5 mL). Diethyl ether (5 mL) was added and the 
organic layer was separated. The aqueous layer was extracted with ethyl acetate 
(3 x 5 mL). The combined organic phases were dried over Na2SO4 and 
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concentrated in vacuo. The title compound was purified by silica gel column 
chromatography (2% EtOAc in Hexanes) to give a clear colorless oil (1.19 g, 97%).  
1H NMR (500 MHz, CDCl3,ppm) δ 6.93 (d, J = 15.9 Hz, 1H), 5.72 (d, J = 15.9 Hz, 
1H), 5.70 (ddt, J = 16.8, 10.2, 7.4 Hz, 1H), 5.06 – 4.99 (m, 2H), 4.19 (q, J = 7.2 Hz, 
2H), 2.11 (dt, J = 7.3, 1.2 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H), 1.05 (s, 6H); 13C NMR 
(126 MHz, CDCl3) δ 167.3, 157.8, 134.4, 118.1, 117.9, 60.4, 46.5, 36.9, 26.3, 14.4. 
HRMS (EI+): m/z calculated for [C9H14O2]+: 154.0994, found: 154.0990. 
 
 
ethyl (E)-hepta-2,6-dienoate (5g): An oven-dried round bottom flask was flushed 
with argon and triethylphosphonoacetate (1.789 mL, 9.0 mmol, 1.5 equiv) was 
added to a stirring solution of NaH (60% dispersion in mineral oil, 0.359 g, 9.0 
mmol, 1.5 equiv) in anhydrous THF (20 mL) at 0 °C. After 20 minutes, 4-pentenal 
(0.592 mL, 6.0 mmol, 1.0 equiv) was then added dropwise and the reaction was 
stirred for 30 minutes at 0 °C. The reaction was allowed to warm to ambient 
temperature and stirred for an additional 2 hours. The reaction mixture was 
quenched sequentially with a saturated Na2CO3 solution (5 mL), water (5 mL), and 
brine (5 mL). Diethyl ether (5 mL) was added and the organic layer was separated. 
The aqueous layer was extracted with 3 x 5 mL ethyl acetate. The combined 
organic extracts were dried over Na2SO4 and concentrated in vacuo. The title 
compound was purified by silica gel column chromatography (2% EtOAc in 
Hexanes) to give a clear colorless oil (0.814 g, 88% yield). 1H NMR (500 MHz, 
CDCl3, ppm) δ 6.95 (dt, J = 15.6, 6.7 Hz, 1H), 5.79-8.84 (m, 2H), 5.05(dq, J = 17.1, 
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1.6 Hz, 1H), 5.00 (ddt, J = 10.2, 1.8, 1.2 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.33 – 
2.27 (m, 2H), 2.25 – 2.19 (m, 2H), 1.28 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3, ppm) δ 166.8, 148.4, 137.2, 121.8, 115.7, 60.3, 32.2, 31.6, 14.4. HRMS 
(EI+): m/z calculated for [C9H14O2]+: 154.0994,  found: 154.0990. 
 
 
dibenzyl (2E,6E)-octa-2,6-dienedioate (1): A 100 mL 2-neck round bottom flask 
was charged with Ru-2 (G2, 84.9 mg, 0.1 mmol, 0.025 eq) and equipped with a 
Teflon-coated stir bar and a water-cooled reflux condenser. The flask and 
condenser were evacuated and refilled with Ar twice. CH2Cl2 (20 mL) was then 
added, followed by 1,5-cyclooctadiene (491 µL, 4.0 mmol, 1 eq) and benzyl 
acrylate (2.94 mL, 19.2 mmol, 4.8 eq). The resulting mixture was heated to reflux 
under a flow of Ar for 4 hr, and then cooled to ambient temperature. The crude 
mixture was diluted with EtOAc (100 mL) and washed with brine (20 mL). The 
organic extract was dried with Na2SO4 and concentrated in vacuo. The title 
compound was isolated by column chromatography (10-15% EtOAc in Hexanes) 
to give a yellow oil (1.723 g). A sample of this material was used in an oxidative 
cyclization control experiment (see General Procedure A, without Ru catalyst), and 
7% conversion was observed. This result indicates that the isolated dienoate after 
column chromatography likely still contains trace residual Ru. To further remove 
trace Ru, the dienoate was dissolved in Et2O (10 mL) and 1.0 g of Siliabond DMT 
(purchased from Silicycle) was added. The suspension was stirred at ambient 
temperature for 2 hr, whereby the organic phase became a lighter yellow. The 
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mixture was then filtered through a cotton-packed Pasteur pipette and 
concentrated in vacuo to yield a pale yellow oil (1.538 g, 55%). In a repeat of the 
control oxidative cyclization experiment, no conversion was observed, indicating 
that residual Ru contamination is sufficiently low. 1H NMR (300 MHz, CDCl3, ppm) 
δ 7.40 – 7.29 (m, 10H), 6.98 (d, J = 15.7 Hz, 2H), 5.90 (d, J = 15.6 Hz, 2H), 5.18 
(s, 4H), 2.41 – 2.34 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 166.3, 147.7, 136.1, 
128.7, 128.4, 128.4, 122.1, 66.3, 30.6. HRMS (FAB+): m/z calculated for 
[C22H22O4+H]+: 351.1596, found: 351.1581. 
 
 
(2Z,6E)-8-ethoxy-8-oxo octa-2,6-dien-1-yl benzoate: Synthesized by combining 
the crude material from 5 optimization runs of the Z-selective metathesis procedure 
(see General method D) and purified by column chromatography (2% ethyl acetate 
in hexanes). 1H NMR (500 MHz, CDCl3, ppm) δ 8.07 – 8.01 (m, 2H), 7.58 – 7.52 
(m, 1H), 7.46 – 7.40 (m, 2H), 6.95 (dt, J = 15.7, 6.6 Hz, 1H), 5.84 (dt, J = 15.7, 1.5 
Hz, 1H), 5.75 – 5.64 (m, 2H), 4.86 (dd, J = 6.4, 0.9 Hz, 2H), 4.17 (q, J = 7.1 Hz, 
2H), 2.41 – 2.27 (m, 4H), 1.28 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
166.6, 166.6, 147.8, 133.6, 133.1, 130.3, 129.8, 128.5, 124.8, 122.2, 60.8, 60.4, 
32.0, 26.2, 14.4. HRMS (ES+): m/z calculated for [C17H20O4+H]+: 288.1362, found: 
288.1371. 
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ii) General procedures  
 
General procedure A – Optimization of oxidative cyclization conditions 
(Table 1):  
 
To a round bottom flask charged with NaIO4 (85.6 mg, 0.40 mmol, 4 eq) was added 
CeCl3•7H2O (7.5 mg, 0.02 mmol, 0.2 eq) in H2O (0.33 mL). To the suspension was 
added MeCN (1.0 mL) followed by the appropriate ruthenium catalyst (1.25 mol%) 
in EtOAc (0.5 mL). Finally, bisacrylate 1 (35.0 mg, 0.1 mmol, 1 eq) dissolved in 
EtOAc (0.5 mL) was added, and the mixture was stirred vigorously at ambient 
temperature. After 20 minutes, the mixture was quenched with 2 mL of saturated 
Na2S2O3. The mixture was extracted with EtOAc (3 x 5 mL) and the combined 
organic extracts were concentrated in vacuo. Mesitylene (27.8 µL, 0.2 mmol, 2 eq) 
was added as an internal NMR standard. The crude mixture was then dissolved in 
CDCl3 and analyzed by 1H NMR (8 scans, 25 s relaxation delay).  
 
General procedure B – Tandem ring opening cross metathesis – oxidative 
cyclization (Table 2): 
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A 25 mL 2-neck round bottom flask was charged with Ru-4 (7.8 mg, 0.0125 mmol, 
0.05 eq) and equipped with a Teflon-coated stir bar and a water-cooled reflux 
condenser. The flask and condenser were evacuated and refilled with Ar twice. 
CH2Cl2 (2.5 mL) was then added, followed by 1,5-cyclooctadiene (3) (30.7 µL, 0.25 
mmol, 1 eq) and the appropriate acrylate (1.20 mmol, 4.8 eq). The resulting mixture 
was heated at reflux under a flow of Ar for 4 hr, and then cooled to ambient 
temperature.  
Meanwhile, a separate round bottom flask was charged with NaIO4 (513 mg, 2.4 
mmol, 2 times the total expected amount of olefins after the metathesis step). 
CeCl3•7H2O (44.7 mg, 0.12 mmol) in H2O (2 mL) was added, followed by MeCN 
(6 mL). EtOAc (6 mL) was added to the crude metathesis mixture, and this solution 
was then transferred to the oxidant mixture. This resulting brown heterogeneous 
mixture was stirred vigorously for 20 minutes, and then quenched with saturated 
Na2S2O3 (20 mL). The mixture was extracted with EtOAc (3 x 50 mL) and the 
combined organic extracts were dried with Na2SO4 and concentrated in vacuo. The 
title compound was then purified by column chromatography. 
 
General procedure C – Tandem cross metathesis – oxidative cyclization 
(Table 3):  
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A 25 mL 2-neck round bottom flask was charged with Ru-4 (7.8 mg, 0.0125 mmol, 
0.025 eq) and equipped with a Teflon-coated stir bar and a water-cooled reflux 
condenser. The flask and condenser were evacuated and refilled with Ar twice. 
CH2Cl2 (2.5 mL) was then added, followed by the appropriate diene (5) (0.50 mmol, 
1 eq) and the appropriate terminal olefin (4) (0.60 mmol, 1.2 eq, unless otherwise 
specified). The resulting mixture was heated at reflux under a flow of Ar for 4 hr, 
and then cooled to ambient temperature.  
Meanwhile, a separate round bottom flask was charged with NaIO4 (471 mg, 2.2 
mmol, 2 times the total expected amount of olefins after the metathesis step). 
CeCl3•7H2O (41 mg, 0.11 mmol) in H2O (2 mL) was added, followed by MeCN (6 
mL). EtOAc (6 mL) was added to the crude metathesis mixture, and this solution 
was then transferred to the oxidant mixture. This resulting brown heterogeneous 
mixture was stirred vigorously for 20 minutes, and then quenched with saturated 
Na2S2O3 (20 mL). The mixture was extracted with EtOAc (3 x 50 mL) and the 
combined organic extracts were dried with Na2SO4 and concentrated in vacuo. The 
title compound was then purified by column chromatography.  
 
General procedure D – Tandem Z-selective cross metathesis – oxidative 
cyclization (Scheme 2):  
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In a nitrogen filled glove box, a solution of allyl benzoate (81.1 mg, 0.5 mmol, 5.0 
equiv) in THF or 2-MeTHF (50 µL) was added to the diene substrate (0.1 mmol, 
1.0 equiv) in a 8 mL vial. A solution of Ru-5 (0.006 mmol, 4.05 mg in 50 µL THF or 
Me-THF) was added to the vial. The vial was capped with a septum cap, and 
removed from the glove box. An argon inlet and outlet connected to an oil bubbler 
were connected. The argon flow rate was set at one bubble per second. The 
solution was then heated in an oil bath with stirring at 40 °C for 4 hr, and then 
cooled to ambient temperature. Meanwhile in a separate round bottom flask a 
solution of CeCl3•7H2O (14.9 mg, 0.04 mmol) in distilled H2O (667 µL) was added 
to NaIO4 (171 mg, 0.8 mmol, 2.0 equiv relative to the cross metathesis products at 
full conversion). MeCN (2 mL) was added at room temperature. The crude 
metathesis mixture was then added using EtOAc (3 x 667 µL) to rinse the flask 
and ensure complete transfer. The mixture was vigorously stirred at room 
temperature for 20 min and then quenched with 2 mL of a saturated Na2S2O3 
solution. The mixture was extracted with EtOAc (4 x 10 mL), and then concentrated 
under reduced pressure. The crude residue was suspended in Et2O, in which the 
1,2-diol byproduct (from allyl benzoate homodimerization and then 
dihydroxylation) is poorly soluble. The liquid phase was collected by pipette and 
concentrated, and the title compound was purified by thin layer chromatography.  
 
iii) Product Characterization 
 
2a 
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(2a): Synthesized according to General Procedure B using benzyl acrylate (184 
µL, 1.20 mmol). The title compound was isolated by column chromatography (35-
50% EtOAc in hexanes), and impure fractions were repurified using preparatory 
TLC (40% EtOAc in hexanes) to yield a clear oil (99.1 mg, 50%). 1H NMR (400 
MHz, CDCl3) δ 7.40-7.27 (m, 10H), 5.24 (d, J = 12.3 Hz, 2H), 5.19 (d, J = 12.3 Hz, 
2H), 4.48-4.40 (m, 2H), 4.17 (d, J = 1.9 Hz, 2H), 3.86 (br s, 2H), 2.30-2.15 (m, 2H), 
2.10-1.97 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 172.5, 135.3, 128.6, 128.4, 128.2, 
80.5, 73.5, 67.3, 28.1;  HRMS (FAB+): m/z calculated for [C22H24O7+H]+: 401.1600, 
found: 401.1580. 
 
2b  
(2b): For Table 2, entry 2, the title compound was synthesized according to 
General Procedure B using phenyl acrylate (165 µL, 1.20 mmol). Compound 2b 
was isolated by two iterations of column chromatography (35-50% EtOAc in 
hexanes), to yield a white solid (106.4, 57%). For Table 2, entry 3, polybutadiene 
(Mn = 3000, 27.1 mg, 0.25 mmol) was used in place of 1,5-cyclooctadiene, and the 
product was isolated by column chromatography (30-40% EtOAc in hexanes) and 
trituration with ether to yield a white solid (65.7 mg, 35%). See below for a 
procedure on 5.0 mmol scale. Crystals suitable for X-ray diffraction were grown by 
slow diffusion of pentane into a solution of 2b in EtOAc. 1H NMR (400 MHz, CDCl3) 
δ 7.40-7.34 (m, 4H), 7.24-7.20 (m, 2H), 7.09-7.06 (m, 4H), 4.70-4.64 (m, 2H), 4.42 
(d, J = 1.9 Hz, 2H), 3.90 (br s, 2H), 2.42-2.34 (m, 2H),  2.22-2.12 (m, 2H); 13C NMR 
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(101 MHz, CDCl3) δ 171.5, 150.5, 129.5, 126.1, 121.3, 80.8, 73.6, 28.0; HRMS 
(FAB+): m/z calculated for [C20H20O7+H]+: 373.1287, found: 373.1289. 
 
Procedure for 2.5 mmol scale reaction: A 100 mL 2-neck round bottom flask was 
charged with Ru-4 (78 mg, 0.125 mmol, 0.05 eq) and equipped with a Teflon-
coated stir bar and a water-cooled reflux condenser. The flask and condenser were 
evacuated and refilled with Ar twice. CH2Cl2 (12.5 mL) was then added, followed 
by 1,5-cyclooctadiene (307 µL, 2.5 mmol, 1 eq) and phenyl acrylate (1.65 mL, 12.0 
mmol, 4.8 eq). The resulting mixture was heated at reflux under a flow of Ar for 4 
hr, and then cooled to ambient temperature.  
Meanwhile, a separate round bottom flask was charged with NaIO4 (3.85 mg, 18 
mmol, 1.5 times the total expected amount of olefins after the metathesis step). 
CeCl3•7H2O (335.3 mg, 0.9 mmol) in H2O (10 mL) was added, followed by MeCN 
(30 mL). EtOAc (30 mL) was added to the crude metathesis mixture, and this 
solution was then transferred to the oxidant mixture. This resulting brown 
heterogeneous mixture was stirred vigorously for 20 minutes, and then quenched 
with saturated Na2S2O3 (30 mL). The mixture was extracted with EtOAc (3 x 100 
mL) and the combined organic extracts were dried with Na2SO4 and concentrated 
in vacuo. The title compound was then purified by column chromatography (30-
35% EtOAc in hexanes) followed by trituration with ether to yield 964.2 mg (52%).  
 
2c 
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(2c): Synthesized according to General Procedure B using n-butyl acrylate (164 
µL, 1.20 mmol). The THF diol was purified by column chromatography (30-40% 
EtOAc in hexanes), however inseparable impurities remained. This material was 
dissolved in CH2Cl2 (2.5 mL) and triethylamine (0.348 mL, 2.5 mmol) and benzoyl 
chloride (0.173 mL, 1.5 mmol) were then added. The solution was stirred at 
ambient temperature for 2 hours. The crude mixture was diluted with EtOAc (50 
mL), washed with NH4Cl (30 mL) and brine (30 mL), dried with Na2SO4 and 
concentrated in vacuo. The title compound was isolated by column 
chromatography (15-20% EtOAc in hexanes). 1H NMR (400 MHz, CDCl3) δ 8.08 
(dd, J = 8.4, 1.3 Hz, 4H), 7.48 (t, J = 7.5 Hz, 2H), 7.30 (dd, J = 8.2, 7.4 Hz, 4H), 
5.33 (d, J = 4.5 Hz, 2H), 4.67-4.60 (m, 2H), 4.15 (t, J = 6.7 Hz, 4H), 2.14-2.10 (m, 
4H), 1.62-1.52 (m, 4H), 1.35-1.24 (m, 4H), 0.84 (t, J = 7.4 Hz, 6H); 13C NMR (101 
MHz, CDCl3) δ 167.9, 166.3, 133.3, 130.0, 129.1, 128.3, 78.5, 74.6, 65.4, 30.4, 
27.7, 18.9, 13.6; HRMS (FAB+): m/z calculated for [C30H36O9+H]+: 541.2437, 
found: 541.2423. 
 
6a 
(6a): Synthesized according to General Procedure C with diene 5a (84.1 mg, 0.5 
mmol) and benzyl acrylate (92 µL, 0.6 mmol). The title compound was purified by 
column chromatography (25-35% EtOAc in hexanes) to yield a clear oil (114.9 mg, 
65%). 1H NMR (500 MHz, CDCl3) δ 7.37-7.29 (m, 5H), 5.20 (s, 2H), 4.44 (ddd, J = 
8.0, 4.6, 1.8 Hz, 1H), 4.24 (t, J = 7.2 Hz, 1H), 4.21 (qd, J = 7.1, 5.6 Hz, 2H), 4.13 
 S19 
(s, 1H), 4.07 (br s, 2H), 2.23-2.12 (m, 2H), 2.07-1.99 (m, 1H), 1.99-1.91 (m, 1H), 
1.30 (s, 3H), 1.27 (t, J = 7.1 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 175.3, 172.6, 
135.4, 128.6, 128.2, 110.0, 84.1, 80.5, 76.7, 73.8, 67.1, 62.0, 28.1, 25.9, 21.9, 
14.1; HRMS (FAB+): m/z calculated for [C18H24O7+H]+: 353.1600; found: 353.1613. 
 
6b 
(6b): Synthesized according to General Procedure C with diene 5a (84.1 mg, 0.5 
mmol) and phenyl acrylate (83 µL, 0.6 mmol). The title compound was purified by 
column chromatography (30-40% EtOAc in hexanes) to yield a clear oil (111.6 mg, 
66%).1H NMR (500 MHz, CDCl3) δ 7.36 (dd, J = 8.4, 7.5 Hz, 1H), 7.22 (tt, J = 7.2, 
1.3 Hz, 1H), 7.08 (dd, J = 8.6, 1.1 Hz, 1H), 4.62 (ddd, J = 8.0, 3.9, 1.8 Hz, 1H), 
4.35-4.26 (m, 3H), 4.23 (qd, J = 7.1, 1.5 Hz, 2H), 4.04 (br s, 1H), 2.30-2.17 (m, 
2H), 2.17-2.07 (m, 1H), 2.02-1.96 (m, 1H), 1.32 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 175.4, 171.5, 150.6, 129.4, 126.0, 121.4, 84.1, 80.81, 
76.5, 74.4, 62.2, 28.1, 25.9, 22.0, 14.1; HRMS (FAB+): m/z calculated for 
[C17H22O7+H]+: 339.1444; found: 339.1454. 
 
6c 
(6c): Synthesized according to General Procedure C with diene 5a (84.1 mg, 0.5 
mmol) and n-butyl acrylate (86 µL, 0.6 mmol). The title compound was purified by 
column chromatography (30-35% EtOAc in hexanes) to yield a clear oil (96.1 mg, 
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60%). 1H NMR (400 MHz, C6D6) δ 4.47 (br s, 1H), 4.28 (ddd, J = 7.6, 4.7, 1.9 Hz, 
2H), 4.13 (dd, J = 7.1, 6.2 Hz, 1H), 4.08-3.92 (m, 5H), 2.15-2.02 (m, 2H), 1.58-1.41 
(m, 2H), 1.41-1.33 (m, 2H), 1.19 (s, 3H), 1.15 (sex, J = 7.6 Hz, 2H), 0.97 (t, J = 7.1 
Hz, 3H), 0.75 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, C6D6) δ 175.5, 172.9, 84.6, 
81.1, 76.9, 73.9, 65.2, 61.7, 30.8, 28.3, 26.1, 21.9, 19.3, 14.1, 13.8; HRMS (FAB+): 
m/z calculated for [C15H26O7+H]+: 319.1757; found: 319.1751. 
 
6d 
(6d): Synthesized according to General Procedure C modified with the following 
amounts: diene 5a (84.1 mg, 0.5 mmol), cis-acetoxy-2-butene 4d (199 µL, 1.25 
mmol), Ru-4 (15.7 mg, 0.025 mmol, 5 mol%) and CH2Cl2 (2.5 mL) for the 
metathesis step. For the oxidative cyclization step: NaIO4 (856 mg, 4.0 mmol), 
CeCl3•7H2O (74.5 mg, 0.2 mmol), MeCN (11 mL), EtOAc (11 mL), H2O (3.6 mL). 
The title compound was purified by column chromatography (50-55% EtOAc in 
hexanes) to yield a clear oil (86.3 mg, 59%). 1H NMR (500 MHz, CDCl3) δ 4.34-
4.21 (m, 3H), 4.11 (s, 1H), 4.10 (d, J = 0.6 Hz, 1H), 4.05 (ddd, J = 7.7, 5.0, 2.9 Hz, 
1H), 3.82 (s, 1H), 3.70-3.65 (m, 1H), 3.29 (d, J = 7.9 Hz, 1H), 2.08 (s, 3H), 2.20-
1.90 (m, 4H), 1.31 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
175.9, 171.3, 83.9, 79.7, 76.5, 72.3, 66.7, 62.4, 28.5, 25.6, 22.5, 21.1, 14.3. HRMS 
(FAB+): m/z calculated for [C13H22O7+H]+: 291.1444; found: 291.1432.  
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6e 
(6e): Synthesized according to General Procedure C with diene 5b (84.1 mg, 0.5 
mmol) and benzyl acrylate (92 µL, 0.6 mmol). The title compound was purified by 
column chromatography (33-40% EtOAc in hexanes) to yield a clear oil (122.1 mg, 
69%). 1H NMR (400 MHz, CDCl3) δ 7.42-7.30 (m, 5H), 5.30 (d, J = 12.4 Hz, 1H), 
5.20 (d, J = 12.3 Hz, 1H), 4.52 (ddd, J = 8.0, 5.3, 1.5 Hz, 1H), 4.24 (qd, J = 7.2, 
1.5 Hz, 1H), 4.16 (t, J = 7.0 Hz, 1H), 4.13 (s, 1H), 3.59 (br s, 2H), 2.22-2.12 (m, 
1H), 2.09-2.00 (m, 1H), 2.00-1.91 (m, 1H), 1.87-1.78 (m, 1H), 1.45 (s, 3H), 1.29 (t, 
J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 174.8, 172.6, 135.6, 128.5, 128.3, 
128.2, 83.5, 80.6, 76.5, 73.9, 66.9, 62.1, 27.9, 26.4, 23.7, 14.1; HRMS (FAB+): m/z 
calculated for [C18H24O7+H]+: 353.1600; found: 353.1595. 
 
6f 
(6f): Synthesized according to General Procedure C with diene 5b (84.1 mg, 0.5 
mmol) and phenyl acrylate (83 µL, 0.6 mmol). The title compound was purified by 
column chromatography (35-40% EtOAc in hexanes) to yield a clear oil (123.8 mg, 
73%). 1H NMR (400 MHz, CDCl3) δ 7.39 (t, J = 7.6 Hz, 2H), 7.24 (t, J = 7.4 Hz, 
1H), 7.14 (d, J = 7.5 Hz, 2H), 4.69 (ddd, J = 8.1, 5.0, 1.8 Hz, 1H), 4.46 (br s, 1H), 
4.33 (s, 1H), 4.30-4.20 (m, 3H), 3.62 (br s, 1H), 2.32-2.22 (m, 1H), 2.18-2.07 (m, 
1H), 2.06-1.95 (m, 1H), 1.93-1.83 (m, 1H), 1.52 (s, 3H), 1.30 (td, J = 7.2, 0.6 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 174.9, 171.5, 150.7, 129.5, 125.9, 121.4, 83.5, 
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80.9, 76.5, 74.2, 62.3, 28.0, 26.5, 23.8, 14.1; HRMS (FAB+): m/z calculated for 
[C17H22O7+H]+: 339.1444; found: 339.1448. 
 
6g 
(6g): Synthesized according to General Procedure C with diene 5c (91.2 mg, 0.5 
mmol) and phenyl acrylate (83 µL, 0.6 mmol). The title compound was purified by 
column chromatography (30-40% EtOAc in hexanes) to yield a clear oil (128.7 mg, 
73%). 1H NMR (400 MHz, CDCl3) δ 7.37 (t, J = 8.1 Hz, 2H), 7.23 (t, J = 7.4 Hz, 
1H), 7.10 (d, J = 7.6 Hz, 2H), 4.63 (ddd, J = 8.0, 3.2, 1.9 Hz, 1H), 4.39 (d, J = 11.0 
Hz, 1H), 4.33-4.29 (m, 2H), 4.26 (qd, J = 6.5, 1.0 Hz, 2H), 3.97 (d, J = 1.1 Hz, 1H), 
2.30-2.07 (m, 3H), 2.01-1.93 (m, 1H), 1.77-1.67 (m, 1H), 1.59-1.48 (m, 1H), 1.28 
(td, J = 7.2, 0.6 Hz, 3H), 0.86 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
174.6, 171.5, 150.7, 129.4, 125.9, 121.4, 84.0, 80.7, 80.2, 74.9, 62.2, 28.3, 28.0, 
26.1, 14.2, 7.6. HRMS (FAB+): m/z calculated for [C18H24O7+H]+: 353.1600; found: 
353.1608. 
 
6h 
(6h): Synthesized according to General Procedure C with diene 5d (91.2 mg, 0.5 
mmol) and phenyl acrylate (83 µL, 0.6 mmol). The title compound was purified by 
two iterations of column chromatography (30-40% EtOAc in hexanes) to yield a 
clear oil (106.6 mg, 60%). 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 8.4, 7.4 Hz, 
 S23 
2H), 7.24 (t, J = 7.4 Hz, 1H), 7.13 (dd, J = 8.7, 1.2 Hz, 2H), 4.69 (ddd, J = 8.2, 4.8, 
1.8 Hz, 1H), 4.57 (dd, J = 11.0, 1.8 Hz, 1H), 4.35-4.22 (m, 4H), 3.60 (s, 1H), 2.31-
2.22 (m, 1H), 2.18-1.94 (m, 3H), 1.90-1.76 (m, 2H), 1.30 (t, J = 7.1 Hz, 3H), 0.85 
(t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 174.4, 171.6, 150.8, 129.6, 126.0, 
121.6, 83.5, 81.1, 80.2, 74.6, 62.4, 29.9, 28.1, 26.7, 14.4, 8.0. HRMS (FAB+): m/z 
calculated for [C18H24O7+H]+: 353.1600; found: 353.1607. 
 
6i 
(6i): Synthesized according to General Procedure C with diene 5e (113.2 mg, 0.5 
mmol) and phenyl acrylate (83 µL, 0.6 mmol). The title compound was purified by 
column chromatography (30-35% EtOAc in hexanes) to yield a clear oil (84.1 mg, 
42%). 1H NMR (400 MHz, C6D6) δ 7.12 (dd, J = 8.7, 1.3 Hz, 2H), 7.06 (dd, J = 8.8, 
7.1 Hz, 2H), 6.90 (tt, J = 7.3, 1.3 Hz 1H), 5.00 (t, J = 6.9 Hz, 1H), 4.63 (s, 1H), 4.36 
(ddd, J = 7.5, 5.5, 1.8 Hz, 1H), 4.14 (d, J = 10.3 Hz, 1H), 4.06 (dd, J = 10.1, 1.8 
Hz, 1H), 3.97 (qd, J = 7.1, 1.8 Hz, 2H), 3.92-3.81 (m, 2H), 2.42-2.32 (m, 1H), 2.15-
2.06 (m, 1H), 2.05-1.95 (m, 1H), 1.59-1.49 (m, 1H), 0.88 (t, J = 7.1 Hz, 3H), 0.82 
(t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, C6D6) δ 171.3, 170.0, 168.0, 151.4, 129.6, 
126.0, 121.9, 82.1, 81.6, 81.3, 73.9, 63.0, 61.9, 28.1, 27.3, 13.9, 13.8. HRMS 
(FAB+): m/z calculated for [C19H24O9+H]+: 397.1498; found: 397.1480. 
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6j 
(6j): Synthesized according to General Procedure C with diene 5f (91.2 mg, 0.5 
mmol) and benzyl acrylate (92 µL, 0.6 mmol). The title compound was purified by 
column chromatography (25-30% EtOAc in hexanes) to yield a clear oil (139.0 mg, 
76%). 1H NMR (400 MHz, CDCl3) δ 7.41-7.32 (m, 5H), 5.34 (d, J = 12.3 Hz, 1H), 
5.17 (d, J = 12.3 Hz, 1H), 4.67 (d, J = 11.1 Hz, 1H), 4.51 (ddd, J = 10.8, 6.2, 1.3 
Hz, 1H), 4.30-4.10 (m, 4H), 3.94 (d, J = 1.6 Hz, 1H), 3.81 (br s, 1H), 2.32 (t, J = 
11.4 Hz, 1H), 1.65 (dd, J = 12.1, 6.2 Hz, 1H), 1.29 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H), 
1.15 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 173.2, 172.5, 135.0, 128.6, 128.5, 128.3, 
88.6, 78.4, 73.6, 71.9, 67.8, 61.4, 42.3, 40.9, 29.2, 22.0, 14.1; HRMS (FAB+): m/z 
calculated for [C19H26O7+H]+: 367.1757; found: 367.1751. 
 
6k 
(6k): Synthesized according to General Procedure C with diene 5f (91.2 mg, 0.5 
mmol) and phenyl acrylate (83 µL, 0.6 mmol). The title compound was purified by 
two iterations of column chromatography (25-35% EtOAc in hexanes) to yield a 
white solid (110.6 mg, 63%).1H NMR (400 MHz, CDCl3) δ 7.42-7.35 (m, 2H), 7.28-
7.22 (m, 1H), 7.14-7.09 (m, 2H), 4.67 (ddd, J = 10.8, 6.2, 1.5 Hz, 1H), 4.45 (d, J = 
10.1 Hz, 1H), 4.41 (dd, J = 5.8, 1.5 Hz, 1H), 4.22 (qd, J = 7.2, 4.4 Hz, 2H), 4.16 
(dd, J = 10.2, 1.7 Hz, 1H), 3.99 (d, J = 1.6 Hz, 1H), 3.85 (d, J = 5.9 Hz, 1H), 2.40 
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(t, J = 11.4 Hz, 1H), 1.73 (dd, J = 12.1, 6.2 Hz, 1H), 1.32 (s, 3H), 1.28 (t, J = 7.1 
Hz, 2H), 1.20 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 173.3, 171.6, 150.6, 129.7, 
126.4, 121.4, 88.7, 78.8, 73.7, 72.3, 61.7, 42.6, 41.0, 29.4, 22.3, 14.3; HRMS 
(FAB+): m/z calculated for [C18H24O7+H]+: 353.1600; found: 353.1595. 
 
6l 
(6l): Synthesized according to General Procedure D with diene 5a (15.4 mg, 0.1 
mmol) in MeTHF. The crude mixture was first purified by preparatory TLC (40% 
EtOAc in hexanes). The resulting material still contained a significant quantity of 
the dihydroxylated allyl benzoate dimer (2,3-dihydroxybutane-1,4-diyl dibenzoate). 
The impurity was precipitated with 1:1 Et2O:Hexanes (200 µL), and the liquid was 
collected and concentrated in vacuo to yield a clear oil (16.8 mg, containing 6 mol% 
1,2-diol impurity, corrected yield is 45%). 1H NMR (500 MHz, CDCl3) δ 8.04 (dd, J 
= 8.1, 1.5 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.43 (t, J = 7.8 Hz, 2H), 4.44 (dd, J = 
11.5, 3.9 Hz, 1H), 4.33-4.20 (m, 4H), 4.14 (dt, J = 6.9, 4.1 Hz, 1H), 4.07 (dt, J = 
7.1, 5.1 Hz, 1H), 3.90 (br s, 1H), 3.35 (br s, 1H), 2.17-2.06 (m, 2H), 2.02-1.90 (m, 
2H), 1.32 (s, 3H), 1.30 (3, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 175.9, 
166.9, 133.3, 129.9, 129.9, 128.5, 83.6, 80.5, 76.3, 71.6, 66.4, 62.2, 25.9, 25.7, 
22.3, 14.3. HRMS (FAB+): m/z calculated for [C18H25O7]+: 353.1600.; found: 
353.1610. 
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6m 
(6m): Synthesized according to General Procedure D with diene 5g (16.8 mg, 0.1 
mmol) in THF. The title compound was purified by preparatory TLC (50% EtOAc 
in hexanes) to yield a clear oil (10.3 mg, 30%).1H NMR (500 MHz, CDCl3) δ 8.04 
(dd, J = 8.4, 1.3 Hz, 2H), 7.58 – 7.53 (m, 1H), 7.45 – 7.41 (m, 2H), 4.45 – 4.40 (m, 
2H), 4.34 – 4.23 (m, 3H), 4.19 (dt, J = 7.0, 4.0 Hz, 1H), 4.13 (d, J = 1.9 Hz, 1H), 
4.08 (ddd, J = 7.3, 6.0, 4.1 Hz, 1H), 2.23 – 2.14 (m, 2H), 2.10 – 2.03 (m, 1H), 1.97 
– 1.90 (m, 1H), 1.31 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 173.3, 166.9, 
133.3, 129.9, 129.9, 128.6, 80.7, 79.9, 73.1, 71.5, 66.4, 62.1, 27.9, 25.9, 14.3. 
HRMS (ES+): m/z calculated for [C17H23O7]+: 339.1410.; found: 339.1444. 
 
iv) Miscellaneous experiments 
 
Optimization of ring opening cross metathesis: 
A 25 mL 2-neck round bottom flask was charged with Ru-4 (0.02 - 0.05 eq) and 
equipped with a Teflon-coated stir bar and a water-cooled reflux condenser. The 
flask and condenser were evacuated and refilled with Ar twice. CH2Cl2 (2.5 mL) 
was then added, followed by 1,5-cyclooctadiene (3) (30.7 µL, 0.25 mmol, 1 eq) 
and methyl acrylate (1.2-1.5 mmol). The resulting mixture was heated at reflux 
under a flow of Ar, and aliquots were taken at various times for analysis by 1H NMR 
(conversion calculated based on product and poly(cyclooctadiene) integrals).  
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Entry Acrylate (equiv) Ru-4 (mol %) Time (h) Conversion (%) 
1 1.5 2 1 72 
2 1.5 2 2.5 88 
3 1.5 5 1 92 
4 1.5 5 2.5 98 
5 1.2 2 3 75 
6 1.2 2 5 81 
7 1.2 5 3 98 
8 1.2 5 5 99 
 
 
Control experiment: Oxidation of E,Z-diene in the absence of Ru 
 
Reaction performed according to General procedure A, with no ruthenium catalyst 
added. By 1H NMR, no product was observed, and the substrate was recovered 
with >95%. 
 
 
(7a): To a 50 mL Schlenk flask under Ar was added Pd/C (14.4 mg, 0.0136 mmol, 
10%). The flask was evacuated and refilled with Ar, then EtOAc (2.7 mL) was 
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added. The flask was then purged with an H2 balloon five times and allowed to stir 
at ambient temperature with an H2 balloon. After 2.5 hr, the reaction was complete 
by TLC. The crude mixture was filtered over Celite, washed with EtOAc, and 
concentrated in vacuo to yield a clear solid (56.6 mg, 79%). A single crystal suitable 
for x-ray diffraction was grown by slow diffusion of pentane into a solution of 7a in 
EtOAc. 1H NMR (500 MHz, CDCl3) δ 7.0-4.0 (br s), 4.62 (ddd, J = 8.6, 6.9, 1.8 Hz, 
1H), 4.26 (qq, J = 7.1, 3.6 Hz, 2H), 4.21 (dd, J = 7.7, 5.8 Hz, 1H), 4.14 (d, J = 1.8 
Hz, 1H), 2.18-2.05 (m, 2H), 1.97-1.90 (m, 1H), 1.90-1.81 (m, 1H), 1.49 (s, 3H), 
1.30 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, cdcl3) δ 175.1, 174.7, 83.1, 80.2, 77.1, 
73.3, 62.7, 28.0, 26.8, 23.9, 14.3. HRMS (FAB+): m/z calculated for [C11H19O7]+: 
263.1131; found: 263.1129. 
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3. Spectra   
  5a 
  
 S30 
  5b 
 
 
 
  
 S31 
  5c 
 
 
  
 S32 
 5d 
 
 
  
 S33 
 5e
 
 
 S34 
5f
 
  
 S35 
  5g 
 
 
  
 S36 
  1
 
  
 S37 
 
 
 
 
  
 S38 
2a 
 
 
  
 S39 
 2b 
 
 
  
 S40 
2c
 
 
  
 S41 
 6a 
 
  
 S42 
 6b 
 
 
  
 S43 
  6c 
 
 
  
 S44 
  6d
 
 
 
  
 S45 
  6e 
 
  
 S46 
  6f 
 
 
  
 S47 
 
  6g
 
 
  
 S48 
  6h
 
 
  
 S49 
  6i 
 
 
  
 S50 
 6j 
 
  
 S51 
6k
 
  
 S52 
6l 
  
 S53 
 6m 
 
 
  
 S54 
  7a 
 
 
 
